机译:CD3,CD8,CD45RO表达在阶段II / III结直肠癌中的预测值:提高预测价值和诊断质量
Department of Biology University of Barcelona Barcelona Spain;
Department of Pathology Attikon University General Hospital Chaidari Greece;
2nd Department of Pathology National and Kapodistrian University of Athens Chaidari Greece;
2nd Department of Pathology National and Kapodistrian University of Athens Chaidari Greece;
2nd Department of Pathology National and Kapodistrian University of Athens Chaidari Greece;
2nd Department of Pathology National and Kapodistrian University of Athens Chaidari Greece;
3rd Department of surgery National and Kapodistrian University of Athens Chaidari Greece;
2nd Department of Pathology National and Kapodistrian University of Athens Chaidari Greece;
2nd Department of Medicine National and Kapodistrian University of Athens Chaidari Greece;
Artificial Neuron Network; CD3; CD45RO; CD8; Colorectal Cancer; Prognosis;
机译:CD3,CD8,CD45RO表达在阶段II / III结直肠癌中的预测值:提高预测价值和诊断质量
机译:II期或III期散发性结直肠癌患者的CD44v6表达在预测进展方面优于CD44表达
机译:II期或III期散发性结直肠癌患者的CD44v6表达在预测进展方面优于CD44表达
机译:染色体缺失作为早期结直肠癌复发的预测因子
机译:延迟的社会心理预测因素:对大肠癌诊断阶段的影响。
机译:II期或III期散发性结直肠癌患者的CD44v6表达在预测进展方面优于CD44表达
机译:CD133表达不是II期和III期大肠癌的独立预后因素,但可以预测辅助治疗患者的预后更好